David Ludvigson

David Gerald Ludvigson currently works at Nanomix, Inc., as President, Chief Executive Officer & Director from 2013, Nanomix Corp., as Chief Executive Officer & Director from 2023, HX Diagnostics, Inc., as Director, China Stem Cells Holdings Ltd., as Director from 2010, One BioMed Pte Ltd., as Director, and Knight-Ludvigson Advisors LLC, as President from 2009.
Mr. Ludvigson also formerly worked at Black Pearl, Inc., as President & Chief Executive Officer from 2001 to 2003, Boston Therapeutics, Inc., as Chairman, Chief Executive Officer, CFO & Secretary, Corgenix Medical Corp., as Director from 2010 to 2015, Argonaut Technologies, Inc., as Director from 2003 to 2011, Jurilab Oy, as Director, Kiyon, Inc., as Director, Imagion Biosystems Ltd., as Independent Non-Executive Director from 2017 to 2024, Chiron Corp., as Chief Operating Officer & Senior Vice President from 1998 to 2000, Conner Peripherals, Inc., as Senior Vice President-Sales & Marketing, Matrix Pharmaceutical, Inc., as SVP, Chief Operating & Financial Officer in 2000, Ngen, Inc., as President & Chief Operating Officer from 1996 to 2009, Intertrust Technologies Corp., as President from 2000 to 2001, IDEC Pharmaceuticals Corp., as Chief Financial Officer & Senior Vice President from 1992 to 1995, Mips Computer Systems, Inc., as Chief Financial Officer & Executive Vice President, and NetPower Technologies, Inc., as President & Chief Operating Officer from 1996 to 1998.
Mr. Ludvigson received his undergraduate degree and graduate degree from Gies College of Business.